Ryesino Pharmaceuticals Private Limited, a active private limited company, was established on 15 December 1983 in Uttar Pradesh, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U85110UP1983PTC006356. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.83 M.
It upholds a compliant status. Its leadership includes Jaidesh Pal Wason (Managing Director), Renu Wason (Director), Sachin Wason (Director). Past directors included Tarun Wason, Meena Wason, Suresh Kumar Wason. It holds ₹7.65 M open charges and ₹9.50 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 3 B Race Course Dehradun, Uttar Pradesh, Uttar Pradesh, 248001.
U85110UP1983PTC006356
006356
15 December 1983
₹1.00 M
₹0.83 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Ryesino Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jaidesh Pal Wason | Managing Director | 15 Dec 1983 | Current |
| Renu Wason | Director | 18 Dec 1986 | Current |
| Sachin Wason | Director | 27 Mar 2000 | Current |
| Shagun Wason | Director | 01 Jun 2003 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Apr 2019 | Past |
| Pramod Abcsdd | Director | 15 Apr 2019 | Past |
| Pramod Abcsdd | Director | 15 Apr 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ryesino Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 6.5% increase. The company also saw a slight decrease in profitability, with a 1.77% decrease in profit. The company's net worth Soared by an impressive increase of 22.32%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Ryesino Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹7,645,000.00
₹9,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Aug 2025 | Others | ₹1.20 M | Open |
| 18 Nov 2005 | State Bank Of India | ₹6.00 M | Open |
| 08 Sep 2000 | State Bank Of India | ₹0.45 M | Open |
| 22 May 2007 | State Bank Of India | ₹9.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Ryesino Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ryesino Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ryesino Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others amounted to Rs. 1.20 M with Charge ID 101155673 was registered on 20 Aug 2025. was completed.
The activity Ryesino Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Ryesino Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.
Progress on A charge registered on 22 May 2007 via Charge ID 10053997 with State Bank Of India was fully satisfied on 17 Aug 2023. was documented.
A charge with State Bank Of India of Rs. 9.50 M registered on 22 May 2007 with Charge ID 10053997 was modified on 18 Sep 2014. was recorded as a recent event.
The activity A charge with State Bank Of India amounted to Rs. 9.50 M with Charge ID 10053997 was registered on 22 May 2007. was completed.
The CIN of Ryesino Pharmaceuticals Private Limited is U85110UP1983PTC006356.
Ryesino Pharmaceuticals Private Limited is headquartered at 3 B Race Course Dehradun, Uttar Pradesh, Uttar Pradesh, 248001.
Ryesino Pharmaceuticals Private Limited was incorporated on 15 December 1983.
The current directors of Ryesino Pharmaceuticals Private Limited are
The primary industry of Ryesino Pharmaceuticals Private Limited is Trade.
Ryesino Pharmaceuticals Private Limited is unlisted.
The authorized capital of Ryesino Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.83 M.
The compliance status of Ryesino Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX